Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    vs5584
Show Display Options
Rank Status Study
1 Recruiting Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma
Conditions: Non Hematologic Cancers;   Metastatic Cancer;   Lymphoma
Intervention: Drug: VS-5584

Indicates status has not been verified in more than two years